semaglutide and vision loss Wegovy Lawsuit [2026 Update] Weight-Loss Shots Linked to Higher

& Moss, S

Potential Side Effects and Safety Considerations Gastrointestinal adverse effects are the most commonly reported side effects of GLP-1 receptor agonists, occurring in a significant proportion of patients, particularly during treatment initiation and dose escalation

Wegovy is FDA-approved for weight loss and cardiovascular risk reduction, while Rybelsus, like Ozempic, is approved for Type 2 diabetes

Bile acid metabolism and signaling, the microbiota, and metabolic disease

[224] demonstrated that oxidative stress triggers mtDNA leakage, which activates the cGASSTING pathway and induces the secretion of pro-inflammatory cytokines in human iPSC-derived neurons